Immunovant
Matt Biggers is a seasoned professional in the medical device engineering field with extensive experience in research and development. Currently serving as a Senior Manager at Immunovant since April 2024, Matt previously held positions at BD from October 2018 to March 2024, where roles included Associate Staff R&D Engineer and Sr. R&D Engineer, focusing on advancing medical device solutions. Prior experience includes work at MicroVention-Terumo, where Matt led cross-functional teams in developing stroke aspiration devices and filed invention disclosures for innovative devices. Matt’s background includes various engineering roles at Terumo Cardiovascular Systems, research internships at the University of Michigan and University of Pennsylvania, and volunteer work in Nicaragua. Matt holds a Master of Science degree in Bioengineering and Biomedical Engineering from the University of Michigan and a Bachelor of Science degree from the University of North Carolina at Chapel Hill.
This person is not in any teams
This person is not in any offices
Immunovant
6 followers
Immunovant, Inc. is a clinical-stage biopharmaceutical company focused on enabling normal lives for patients with autoimmune diseases. Immunovant is developing IMVT-1401, a novel, fully human anti-FcRn monoclonal antibody, as a subcutaneous injection for the treatment of autoimmune diseases mediated by pathogenic IgG antibodies.